“…Many causes of increased cutaneous FDG activity have been reported, in particular melanoma or skin lymphoma, which can be indication for FDG PET. 8,9 More unusual cancers such as Merkel cell carcinoma, 10 metastases of solid tumors, 8,11,12 eccrine porocarcinoma, 13 or granulomatous slack skin 14 can present an FDG uptake. A cutaneous uptake can also be observed in benign lesions such as infectious pathologies 15 or dermatofibroma 16 or in benign conditions, such as stomas, hernias, postoperative wound healing, or dose infiltrations.…”